Adjuvant carboplatin added to standard anthracycline/taxane chemotherapy significantly improves outcomes in early ...
Island Passage Exploration Reports on First Porphyry Copper-Style Mineralization Encountered on its EL02 Project Bougainville ...
At the recent American Society of Hematology annual meeting, phase I data highlighted a next-generation, CD19-targeted, interleukin-18-secreting "armored" CAR T-cell therapy that is designed to ...
2don MSN
Grading every MLB GM's offseason on the curve they deserve: Stearns, Breslow need to get aggressive
While it's important to make it clear that the offseason is nowhere near over, enough time has gone by and enough moves have been made in the MLB offseason that ...
Toyota-owned luxury automaker Lexus makes a lot of SUVs, too many to refresh every year, in fact. For the 2026 model year, ...
Regal Gem (Derek leung, No 7) eventually edging out Never Too Soon (Zac Purton) by a short head in the Class 3 Harbour View ...
The USC Trojans' 9-3 regular season was a year of offseason hype turned into production, from quarterback Jayden Maiava's improvement, to wide receiver Makai Le ...
There has been an explosion of newer HER2-directed therapies, including monoclonal antibodies, novel antibody-drug conjugates ...
India’s chip push is moving beyond fabs into the harder layer—chemicals, gases, and materials. These 3 Indian players are ...
Learn more about whether Legend Biotech Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Iamgold's Q3'25 report shows mixed results and a major acquisition. Read about the recent performance and investment outlook.
Although frontline maintenance treatment with fuzuloparib monotherapy produced a progression-free survival (PFS) benefit in patients with newly diagnosed advanced ovarian cancer, the addition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results